Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.32 BRL | -6.86% | -1.48% | -12.26% |
May. 08 | Transcript : Wilson Sons S.A., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | EARNINGS: International Biotechnology bullish; Andrews Sykes profit up | AN |
Sales 2024 * | 469M 2.46B | Sales 2025 * | 544M 2.85B | Capitalization | 1.26B 6.62B |
---|---|---|---|---|---|
Net income 2024 * | 69M 362M | Net income 2025 * | 77M 404M | EV / Sales 2024 * | 3.73 x |
Net Debt 2024 * | 484M 2.54B | Net Debt 2025 * | 464M 2.43B | EV / Sales 2025 * | 3.17 x |
P/E ratio 2024 * |
18.3
x | P/E ratio 2025 * |
16.2
x | Employees | 3,800 |
Yield 2024 * |
2.75% | Yield 2025 * |
3.1% | Free-Float | 43.48% |
Latest transcript on Wilson Sons S.A.
1 day | -6.86% | ||
1 week | -0.52% | ||
Current month | -0.52% | ||
1 month | -8.54% | ||
3 months | -13.00% | ||
6 months | -3.04% | ||
Current year | -12.26% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 15-12-31 | |
Chairman | 64 | 93-12-31 | |
Chief Operating Officer | 67 | 79-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Salomon
BRD | Director/Board Member | 66 | - |
Chairman | 64 | 93-12-31 | |
Director/Board Member | 74 | 90-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.23% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 15.32 | +1.06% | 278,200 |
24-06-05 | 15.16 | -0.66% | 378,200 |
24-06-04 | 15.26 | -0.07% | 348,100 |
24-06-03 | 15.27 | -0.84% | 475,700 |
24-05-31 | 15.4 | -0.96% | 1,968,200 |
Delayed Quote Sao Paulo, June 06, 2024 at 04:06 pm EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.26% | 1.26B | |
+43.35% | 11.6B | |
+17.23% | 6.16B | |
+0.53% | 2.44B | |
-10.71% | 2.07B | |
+5.11% | 1.75B | |
+23.52% | 1.06B | |
+19.15% | 1.03B | |
-.--% | 1.01B | |
+11.85% | 702M |
- Stock Market
- Equities
- PORT3 Stock